JIC
EXAS

Joel Isaacson & Co’s Exact Sciences EXAS Stock Holding History

Joel Isaacson & Co’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,300
Closed -$234K – 463
2025
Q4 		$234K Buy
+2,300
New +$185K 0.01% 411

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Joel Isaacson & Co's EXAS Position: Q1 2026 in Review

Joel Isaacson & Co sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,300 shares — an estimated $234K sold.

Joel Isaacson & Co first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $234K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Joel Isaacson & Co reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Joel Isaacson & Co sold 2,300 Exact Sciences shares in Q1 2026, an estimated $234K.
  • Joel Isaacson & Co first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
  • Joel Isaacson & Co's Exact Sciences position peaked at $234K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Joel Isaacson & Co's 13F filing for Q1 2026, filed 23 Apr 2026.